Active
SME

Curis Lifesciences Ltd

Curis Lifesciences Ltd IPO opened on 07 Nov 2025 and closed on 11 Nov 2025, with a price band of ₹120–₹128 per share. The IPO had a lot size of 1000 shares, requiring a minimum investment of ₹2,56,000 per lot at the upper price band. The issue size was ₹27.52 crore, and the shares get listed on 14 Nov 2025.

Curis Lifesciences Ltd IPO Details

Listing Date

14 Nov 2025

Bid Price

₹120 - ₹128

Lot Size

1000 Shares

Minimum Investment

₹2,56,000 / 2 Lots

Issue Size

₹27.52 Cr

Key Dates to Track

    Here are the important dates you need to know in order to participate in this IPO

tick

Offer Start Date

7th Nov

tick

Offer End Date

11th Nov

tick

Allotment Date

12th Nov

tick

Refund Initiation

13th Nov

tick

Demat Transfer

13th Nov

tick

Listing Date

14th Nov

About Curis Lifesciences Ltd IPO

Incorporated in 2010, Curis Lifesciences Limited is a pharmaceutical company engaged in developing, manufacturing, and distributing a diverse portfolio of healthcare products. The company’s operations span both domestic and international markets, focusing on the production of general pharmaceutical tablets, capsules, oral liquids, external preparations, and sterile ophthalmic ointments. Curis Lifesciences caters to a wide client base, serving over 100 corporate customers through loan licence and contract manufacturing arrangements, while also promoting its own brands in markets such as Yemen and Kenya. Its modern manufacturing facility in Sanand, Gujarat, is equipped with advanced technology and follows strict quality control standards to maintain consistency and safety across all products.
 

The company’s business model is divided into three main categories — loan licence manufacturing, contract manufacturing, and direct export or own brand marketing. Under the loan licence vertical, clients provide raw materials, excipients, and necessary documentation, while Curis Lifesciences undertakes the production process under the supervision of a customer-appointed chemist. This model ensures flexibility and compliance with client requirements. The company employs 95 permanent staff as of July 31, 2025, and continues to strengthen its position in the pharmaceutical industry by combining manufacturing expertise with adherence to regulatory standards and customer-oriented practices.

Curis Lifesciences Ltd Shareholding Pattern

  Pre-Issue Post-Issue
Promoter Group 92.68% 68.03%
Public Group 7.32% 31.97%

Curis Lifesciences Ltd IPO Reservation

QIB Shares Offered 4,08,000 (18.98%)
NII (HNI) Shares Offered 3,08,000 (14.33%)
Retail Shares Offered 7,16,000 (33.3%)
Anchor Investor Shares Offered 6,10,000 (28.37%)
Total Shares Offered 21,50,000
Total Shares With Anchor Investor 21,50,000

Curis Lifesciences Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 2 2,000 ₹2,56,000
Retail (Max) 2 2,000 ₹2,56,000
S HNI (Min) 3 3,000 ₹3,84,000
S HNI (Max) 7 7,000 ₹8,96,000
B HNI (MIN) 8 8,000 ₹10,24,000

Curis Lifesciences Ltd IPO Anchor Portion Size

Bid Date November 06, 2025
Shares Offered 6,09,000
Anchor Investment Details 7.7952

Curis Lifesciences Ltd IPO registrar

MUFG Intime India Pvt Ltd
Phone Number +91 810 811 4949;
Email Id curislifesciences.smeipo@in.mpms.mufg.com
Website https://in.mpms.mufg.com

Curis Lifesciences Ltd IPO Lead Manager

1. Finaax Capital Advisors Private Limited

Curis Lifesciences Ltd Financial Information

March 31, 2025 March 31, 2024 March 31, 2023
Net Worth ₹16.23 Cr ₹5.68 Cr ₹0.32 Cr
Reserves and Surplus ₹10.29 Cr ₹5.18 Cr ₹-0.18 Cr
Total Borrowing ₹15.62 Cr ₹17.09 Cr ₹16.19 Cr

Strength of Curis Lifesciences Ltd

  • Experienced Promoters and Management Team.
  • Wide range of Products.
  • Strategic Location of Manufacturing Facility.
  • Scalable Business Model.
  • Quality assurance.

Risks Involved

  • Our manufacturing facility is concentrated in Sanand, Ahmedabad, Gujarat, exposing us to risks from economic, regulatory, political, and other regional changes, including natural disasters, which could negatively impact our business operations, financial performance, and overall condition.
  • As a pharmaceutical company, we operate in a highly regulated industry where our business relies on obtaining approvals from relevant regulatory and health authorities. Delays or failures in securing or renewing these essential approvals, registrations, or changes in the regulatory environment for marketing our products in regulated markets could have a significant impact on our business and strategy, ultimately affecting our overall profitability.
  • Our business operations are subject to fluctuations in raw material prices.
  • The company relies on a limited number of customers for its sales, and the loss of any major customer could adversely impact our revenue and profitability.
  • The company relies on a limited number of suppliers for product procurement, and the loss of any key supplier could impact our business operations.
  • We depend on a limited number of States for a significant portion of our revenue from operations. The loss of any of our major customer in this States due to any adverse development or significant reduction in business from our major customer may adversely affect our business, financial condition, results of operations and future prospects.
  • Our Company is dependent on a few countries. Loss of any of these large countries may affect our business operations.
  • Our Company depends on some of our Products which contributes 100% of the total revenue of the company. The loss of any of this major Products due to any adverse development or significant reduction in business from our major customer may adversely affect our business, financial condition, results of operations and future prospects.
  • The Statutory Auditor and the Peer Review Auditor of the company are not same.
  • There are certain discrepancies/errors which have occurred in some of our corporate secretarial records relating to forms filed with the RoC and other provisions of Companies Act, 2013. Any penalty or action taken by any regulatory authorities in future.
stock

Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Industry Outlook of Curis Lifesciences IPO

  • The Indian pharmaceutical industry is recognised globally for producing generic medicines and affordable vaccines. Over time, it has evolved into a key sector, ranking third globally by volume and 14th by value, contributing about 1.72% to India’s GDP.

  • According to ICRA, the industry is expected to record a growth rate of around 9–11% in FY2024.

  • In FY2023, the Indian pharma market achieved nearly 5% year-on-year growth, touching approximately USD 49.78 billion. Between FY2018 and FY2023, the industry maintained a compound annual growth rate (CAGR) of 6–8%, mainly supported by an 8% rise in exports and a 6% growth in domestic demand.

  • The key segments within the pharmaceutical sector include generic medicines, over-the-counter (OTC) drugs, active pharmaceutical ingredients (APIs) or bulk drugs, vaccines, contract research and manufacturing services (CRAMS), and biosimilars and biologics.

  • The market size of the Indian pharmaceutical sector continues to expand steadily.

Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Curis Lifesciences IPO.

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
Aarvee Engineering Consultants Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aastha Spintex Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Absolute Project India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AceVector Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Adroit Industries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanta Enterprises Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advit Jewels Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aggcon Equipments International Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alcobrew Distilleries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allied Engineering Works Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alpine Texworld Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Annu Projects Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AOne Steels India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
APPL Containers Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ardee Engineering Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
EMIAC TECHNOLOGIES LIMITED IPO
Bidding Period
27th Mar 2026 - 4th Apr 2026
Price Range
₹93.0 - 98.0
IPO Size
₹32,00,00,000
SAFETY CONTROLS AND DEVICES LIMITED IPO
Bidding Period
6th Apr 2026 - 4th Apr 2026
Price Range
₹75.0 - 80.0
IPO Size
₹48,00,00,000
VIVID ELECTROMECH LIMITED IPO
Bidding Period
25th Mar 2026 - 3rd Mar 2026
Price Range
₹528.0 - 555.0
IPO Size
₹1,31,00,00,000
SAI PARENTERAL'S LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹372.0 - 392.0
IPO Size
₹4,09,00,00,000
AMIR CHAND JAGDISH KUMAR EXPORTS LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹201.0 - 212.0
IPO Size
₹4,40,00,00,000
HIGHNESS MICROELECTRONICS LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹114.0 - 120.0
IPO Size
₹22,00,00,000
POWERICA LIMITED IPO
Bidding Period
24th Mar 2026 - 3rd Mar 2026
Price Range
₹375.0 - 395.0
IPO Size
₹11,00,00,00,000
TIPCO ENGINEERING INDIA LIMITED IPO
Bidding Period
23rd Mar 2026 - 3rd Mar 2026
Price Range
₹84.0 - 89.0
IPO Size
₹61,00,00,000
SPECIALITY MEDICINES LIMITED IPO
Bidding Period
20th Mar 2026 - 3rd Mar 2026
Price Range
₹117.0 - 124.0
IPO Size
₹29,00,00,000
CENTRAL MINE PLANNING AND DESIGN INSTITUTE LIMITED IPO
Bidding Period
20th Mar 2026 - 3rd Mar 2026
Price Range
₹163.0 - 172.0
IPO Size
₹18,42,00,00,000
NOVUS LOYALTY LIMITED IPO
Bidding Period
17th Mar 2026 - 3rd Mar 2026
Price Range
₹139.0 - 146.0
IPO Size
₹60,00,00,000
GSP CROP SCIENCE LIMITED IPO
Bidding Period
16th Mar 2026 - 3rd Mar 2026
Price Range
₹304.0 - 320.0
IPO Size
₹4,00,00,00,000
INNOVISION LIMITED IPO
Bidding Period
10th Mar 2026 - 3rd Mar 2026
Price Range
₹494.0 - 519.0
IPO Size
₹3,06,00,00,000
RAAJMARG INFRA INVESTMENT TRUST IPO
Bidding Period
11th Mar 2026 - 3rd Mar 2026
Price Range
₹99.0 - 100.0
IPO Size
₹60,00,00,00,000
APSIS AEROCOM LIMITED IPO
Bidding Period
11th Mar 2026 - 3rd Mar 2026
Price Range
₹104.0 - 110.0
IPO Size
₹36,00,00,000
RAJPUTANA STAINLESS LIMITED IPO
Bidding Period
9th Mar 2026 - 3rd Mar 2026
Price Range
₹116.0 - 122.0
IPO Size
₹2,55,00,00,000
SRINIBAS PRADHAN CONSTRUCTIONS LIMITED IPO
Bidding Period
6th Mar 2026 - 3rd Mar 2026
Price Range
₹91.0 - 98.0
IPO Size
₹20,00,00,000
ELFIN AGRO INDIA LIMITED IPO
Bidding Period
5th Mar 2026 - 3rd Mar 2026
Price Range
₹47.0 - 47.0
IPO Size
₹25,00,00,000
SEDEMAC MECHATRONICS LIMITED IPO
Bidding Period
4th Mar 2026 - 3rd Mar 2026
Price Range
₹1287.0 - 1352.0
IPO Size
₹10,87,00,00,000
ACETECH ECOMMERCE LIMITED IPO
Bidding Period
27th Feb 2026 - 3rd Mar 2026
Price Range
₹106.0 - 112.0
IPO Size
₹49,00,00,000
  • All
  • MainBoard
  • SME
GSP CROP SCIENCE LIMITED IPO
Issue Prize
320.00
Listing Day Close
356.10(11.25%)
INNOVISION LIMITED IPO
Issue Prize
519.00
Listing Day Close
372.80(-28.13%)
RAAJMARG INFRA INVESTMENT TRUST IPO
Issue Prize
100.00
Listing Day Close
106.83(7.00%)
APSIS AEROCOM LIMITED IPO
Issue Prize
110.00
Listing Day Close
160.65(46.36%)
RAJPUTANA STAINLESS LIMITED IPO
Issue Prize
122.00
Listing Day Close
112.90(-7.38%)
SRINIBAS PRADHAN CONSTRUCTIONS LIMITED IPO
Issue Prize
98.00
Listing Day Close
104.40(6.12%)
ELFIN AGRO INDIA LIMITED IPO
Issue Prize
47.00
Listing Day Close
47.60(2.13%)
SEDEMAC MECHATRONICS LIMITED IPO
Issue Prize
1352.00
Listing Day Close
1452.10(7.40%)
ACETECH ECOMMERCE LIMITED IPO
Issue Prize
112.00
Listing Day Close
117.60(5.36%)
STRIDERS IMPEX LIMITED IPO
Issue Prize
72.00
Listing Day Close
66.50(-6.94%)
OMNITECH ENGINEERING LIMITED IPO
Issue Prize
227.00
Listing Day Close
205.15(-9.69%)
YAAP DIGITAL LIMITED IPO
Issue Prize
145.00
Listing Day Close
133.35(-8.28%)
PNGS REVA DIAMOND JEWELLERY LIMITED IPO
Issue Prize
386.00
Listing Day Close
413.95(7.25%)
SHREE RAM TWISTEX LIMITED IPO
Issue Prize
104.00
Listing Day Close
73.45(-29.81%)
CLEAN MAX ENVIRO ENERGY SOLUTIONS LIMITED IPO
Issue Prize
1053.00
Listing Day Close
867.90(-17.57%)
MOBILISE APP LAB LIMITED IPO
Issue Prize
80.00
Listing Day Close
67.30(-16.25%)
KIAASA RETAIL LIMITED IPO
Issue Prize
127.00
Listing Day Close
116.85(-7.87%)
ACCORD TRANSFORMER AND SWITCHGEAR LIMITED IPO
Issue Prize
46.00
Listing Day Close
52.50(15.22%)
GAUDIUM IVF AND WOMEN HEALTH LIMITED IPO
Issue Prize
79.00
Listing Day Close
80.48(1.27%)
MANILAM INDUSTRIES INDIA LIMITED IPO
Issue Prize
69.00
Listing Day Close
52.45(-24.64%)

Frequently Asked Questions

What is Curis Lifesciences Ltd IPO?

Answer Field

Curis Lifesciences Ltd IPO is a SME IPO of 21,50,000 equity shares of a face value of ₹10 aggregating up to ₹27.52 Crores. The issue is priced at ₹120 to ₹128 per share. The minimum order quantity is 1000 Shares. The IPO opens on November 07, 2025, and closes on November 11, 2025. MUFG Intime India Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE-SME.

When Curis Lifesciences Ltd IPO will open?

Answer Field

The Curis Lifesciences Ltd IPO opens on November 07, 2025 and closes on November 11, 2025.

What is the lot size of Curis Lifesciences Ltd?

Answer Field

Curis Lifesciences Ltd lot size is 1000 shares, and the minimum amount required is ₹2,56,000.

How to apply for Curis Lifesciences Ltd IPO?

Answer Field

You can apply in Curis Lifesciences Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Curis Lifesciences Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Curis Lifesciences Ltd IPO will be done on November 12, 2025, and the allotted shares will be credited to your demat account by November 13, 2025.

When is Curis Lifesciences Ltd IPO listing date?

Answer Field

The Curis Lifesciences Ltd listing date is November 14, 2025.

Who is the registrar of Curis Lifesciences Ltd IPO?

Answer Field

The registrar of Curis Lifesciences Ltd IPO is MUFG Intime India Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Finaax Capital Advisors Private Limited will be the book-running lead manager of this IPO.

What is the fresh issue of Curis Lifesciences Ltd IPO?

Answer Field

The fresh issue size is ₹27.52 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Curis Lifesciences Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 1000 shares and ₹2,56,000 amount.

How can I approve the UPI mandate request for Curis Lifesciences Ltd IPO?

Answer Field

To apply for Curis Lifesciences Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Curis Lifesciences Ltd?

Answer Field

The price of each Curis Lifesciences Ltd share will be ranging in between ₹120 to ₹128 per share.

What is the cut-off time for the UPI mandate for Curis Lifesciences Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, November 11, 2025.

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|